Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study

OBJECTIVES: To estimate the costs and healthcare resources of patients with diabetic macular oedema (DME) who received intravitreal antivascular endothelial growth factor (anti-VEGF) agents or a dexamethasone intravitreal implant (DEX-implant) in Korea. DESIGN: Retrospective cohort study. SETTING: T...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open
Autori principali: Cho, HyunJeong, Choi, Kyung Seek, Lee, Joo Yong, Lee, Donghwan, Choi, Nam-Kyong, Lee, YouKyung, Bae, SeungJin
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2019
Soggetti:
Public Health
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6756349/
https://ncbi.nlm.nih.gov/pubmed/31542758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-030930
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi